These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32757155)

  • 1. Factors affecting performance and manufacturability of naproxen Liqui-Pellet.
    Lam M; Nokhodchi A
    Daru; 2020 Dec; 28(2):567-579. PubMed ID: 32757155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form.
    Lam M; Ghafourian T; Nokhodchi A
    Drug Deliv Transl Res; 2020 Feb; 10(1):43-58. PubMed ID: 31286452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid releasing naproxen Liqui-Pellet using effervescent agent and neusilin US2.
    Lam M; Asare-Addo K; Nokhodchi A
    Iran J Basic Med Sci; 2021 Jan; 24(1):108-115. PubMed ID: 33643578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.
    Lam M; Asare-Addo K; Nokhodchi A
    AAPS PharmSciTech; 2021 Mar; 22(3):85. PubMed ID: 33650023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liqui-Mass Technology as a Novel Tool to Produce Sustained Release Liqui-Tablet Made from Liqui-Pellets.
    Lam M; Nashed N; Nokhodchi A
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquisolid Pellets and Liqui-Pellets Are Not Different.
    Pezzini BR; Beringhs AO; Ferraz HG; Silva MAS; Stulzer HK; Sonaglio D
    AAPS PharmSciTech; 2020 Jan; 21(2):72. PubMed ID: 31953566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquisolid System and Liqui-Mass System Are Not the Same.
    Lam M; Ghafourian T; Nokhodchi A
    AAPS PharmSciTech; 2020 Mar; 21(3):105. PubMed ID: 32180042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
    Maghsoodi M
    AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of naproxen-loaded solid SMEDDSs prepared by spray drying: the effect of the polysaccharide carrier and naproxen concentration.
    Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
    Int J Pharm; 2015 May; 485(1-2):215-28. PubMed ID: 25772420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.
    Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
    Drug Dev Ind Pharm; 2015; 41(9):1548-57. PubMed ID: 25308746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
    Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
    Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming.
    Barmpalexis P; Grypioti A; Eleftheriadis GK; Fatouros DG
    AAPS PharmSciTech; 2018 Feb; 19(2):741-752. PubMed ID: 28980185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
    Pavloková S; Muselík J; Sabadková D; Bernatová S; Samek O; Neumann D; Franc A
    Eur J Pharm Sci; 2019 Apr; 132():86-95. PubMed ID: 30825510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.